The focus here is primarily on optimizing scientific coordination between the authorities. The goal, FDA said, is to establish a common understanding of the regulatory requirements for generic drugs. In addition, the forum is a platform where confidential review issues and assessments can be discussed and aligned. There is an opportunity to share safety reports with each other and discuss safety issues in order to build "a global safety net for generic drugs".
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.